— Know what they know.
Not Investment Advice

XGN NASDAQ

Exagen Inc.
1W: -6.3% 1M: +8.8% 3M: +85.7% YTD: +35.3% 1Y: -25.6% 3Y: +222.9% 5Y: -40.1%
$8.17
+0.28 (+3.55%)
 
Weekly Expected Move ±6.8%
$7 $8 $8 $9 $9
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 58 · $197.4M mcap · 14M float · 2.36% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$58M +29.8% ▲
5Y CAGR: -5.8%
Total Liabilities
$41M +15.4% ▲
5Y CAGR: +2.1%
Shareholders Equity
$17M +82.9% ▲
5Y CAGR: -16.0%
Cash & Investments
$32M +46.2% ▲
5Y CAGR: -10.9%
Total Debt
$5M -76.5% ▼
5Y CAGR: -27.5%
Net Debt
-$27M -2867.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$99M$62M$36M$22M$32M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$99M$62M$36M$22M$32M
Net Receivables$10M$6M$7M$8M$11M
Inventory$0$0$0$0$0
Other Current Assets$490K$236K$2M$859K$6M
Total Current Assets$113M$73M$48M$36M$49M
Property, Plant & Equip.$5M$13M$8M$8M$8M
Goodwill & Intangibles$6M$0$0$0$0
Long-Term Investments$0$0$0$0$200K
Other Non-Current Assets$433K$528K$616K$550K$556K
Total Non-Current Assets$11M$14M$9M$8M$9M
Total Assets$123M$86M$57M$45M$58M
— Liabilities —
Accounts Payable$2M$3M$3M$4M$4M
Short-Term Debt$0$190K$264K$423K$3M
Deferred Revenue$0$0$0$0$675K
Other Current Liabilities$0$445K$0$0$6M
Total Current Liabilities$9M$10M$12M$14M$14M
Long-Term Debt$27M$29M$19M$20M$2M
Other Non-Current Liab.$1M$867K$357K$157K$24M
Total Non-Current Liabilities$29M$34M$22M$22M$26M
Total Liabilities$39M$44M$34M$35M$41M
— Equity —
Common Stock$16K$17K$17K$18K$23K
Retained Earnings-$208M-$256M-$279M-$294M-$314M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$85M$42M$23M$10M$17M
Total Liabilities & Equity$123M$86M$57M$45M$58M
— Key Metrics —
Total Debt$28M$35M$23M$23M$5M
Net Debt-$71M-$27M-$13M$969K-$27M
Total Investments$0$0$0$0$200K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms